These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

867 related articles for article (PubMed ID: 3668980)

  • 21. Cold-induced coronary Raynaud's phenomenon in patients with systemic sclerosis.
    Lekakis J; Mavrikakis M; Emmanuel M; Prassopoulos V; Papazoglou S; Papamichael C; Moulopoulou D; Kostamis P; Stamatelopoulos S; Moulopoulos S
    Clin Exp Rheumatol; 1998; 16(2):135-40. PubMed ID: 9536388
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Controlled study of nifedipine in the treatment of Raynaud's phenomenon].
    Kahan A; Weber S; Amor B; Saporta L; Hodara M; Degeorges M
    Rev Rhum Mal Osteoartic; 1982 Apr; 49(5):337-43. PubMed ID: 6285445
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Local cold exposure test with a new arterial photoplethysmographic sensor in healthy controls and patients with secondary Raynaud's phenomenon.
    Hahn M; Hahn C; Jünger M; Steins A; Zuder D; Klyscz T; Büchtemann A; Rassner G; Blazek V
    Microvasc Res; 1999 Mar; 57(2):187-98. PubMed ID: 10049666
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cold stimulus fingertip lacticemy test--an effective method to monitor acute therapeutic intervention on primary Raynaud's phenomenon and systemic sclerosis.
    Fontenelle SM; Kayser C; Pucinelli ML; Andrade LE
    Rheumatology (Oxford); 2008 Jan; 47(1):80-3. PubMed ID: 18077495
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Evaluation of digital venous reactivity to cold by plethysmographic measurement of compliance to cold and hot. Application of the method to 80 patients with Raynaud's phenomena and 36 controls].
    Planchon B; de Faucal P; Grolleau JY
    J Mal Vasc; 1986; 11(1):80-4. PubMed ID: 3944526
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reactive hyperemia in patients with Raynaud's phenomenon.
    Russell A; Kappagoda T
    J Rheumatol; 1988 Nov; 15(11):1653-7. PubMed ID: 3236299
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prazosin treatment of Raynaud's phenomenon: a double blind single crossover study.
    Russell IJ; Lessard JA
    J Rheumatol; 1985 Feb; 12(1):94-8. PubMed ID: 3884807
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Raynaud's phenomenon. Photoelectric plethysmography of the fingers of persons with and without Raynaud's phenomenon during cooling and warming up.
    Wouda AA
    Acta Med Scand; 1977; 201(6):519-23. PubMed ID: 878907
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Esophageal motility in Raynaud's disease, systemic scleroderma and presclerodermal Raynaud's syndrome].
    Hostein J; Bost R; Carpentier P; Franco A; Fournet J
    Gastroenterol Clin Biol; 1985 Feb; 9(2):130-5. PubMed ID: 3979734
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The peripheral vascular effects of nifedipine in Raynaud's syndrome associated with scleroderma: a double blind crossover study.
    Finch MB; Dawson J; Johnston GD
    Clin Rheumatol; 1986 Dec; 5(4):493-8. PubMed ID: 3816096
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acute effects of misoprostol on digital circulation in patients with Raynaud's phenomenon.
    Wise RA; Wigley F
    J Rheumatol; 1994 Jan; 21(1):80-3. PubMed ID: 8151594
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of clonazepam on Raynaud's phenomenon and fingertip ulcers in scleroderma.
    Colakoğlu M; Cobankara V; Akpolat T
    Ann Pharmacother; 2007 Sep; 41(9):1544-7. PubMed ID: 17666574
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Toe systolic blood pressure after local cooling in primary Raynaud's phenomenon.
    Kurozawa Y; Nasu Y
    Int Angiol; 1994 Sep; 13(3):215-7. PubMed ID: 7822896
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of rewarming curves in Raynaud's phenomenon of various aetiologies.
    Salem KM; Baker M; Hilliam RM; Davies S; Deighton C; Bainbridge LC; Manning G
    J Hand Surg Eur Vol; 2009 Oct; 34(5):621-6. PubMed ID: 19687085
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of sympathetic blockade and cooling in Raynaud's phenomenon.
    Engelhart M
    Clin Physiol; 1990 Mar; 10(2):131-6. PubMed ID: 2318024
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nifedipine and Raynaud's phenomenon associated with connective tissue diseases.
    Kahan A; Weber S; Amor B; Menkes CJ; Hodara M; Degeorges M
    Int Angiol; 1985; 4(2):221-3. PubMed ID: 3831143
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of digital artery adrenoceptors in Raynaud's disease.
    Cooke JP; Creager SJ; Scales KM; Ren C; Tsapatsaris NP; Beetham WP; Creager MA
    Vasc Med; 1997; 2(1):1-7. PubMed ID: 9546943
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Laser-Doppler measurement of digital blood flow regulation in normals and in patients with Raynaud's phenomenon.
    Kristensen JK; Engelhart M; Nielsen T
    Acta Derm Venereol; 1983; 63(1):43-7. PubMed ID: 6191488
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Measurement of cold challenge responses in primary Raynaud's phenomenon and Raynaud's phenomenon associated with systemic sclerosis.
    O'Reilly D; Taylor L; el-Hadidy K; Jayson MI
    Ann Rheum Dis; 1992 Nov; 51(11):1193-6. PubMed ID: 1466594
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of long-term ketanserin treatment on 5-HT levels, platelet aggregation and peripheral circulation in patients with Raynaud's phenomenon. A double-blind, placebo-controlled cross-over study.
    Arneklo-Nobin B; Elmér O; Akesson A
    Int Angiol; 1988; 7(1):19-25. PubMed ID: 3290356
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 44.